- Home
- TRIB vs NAII Comparison
TRIB vs NAII Comparison
Compare TRIB & NAII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRIB
- NAII
- Stock Information
- Founded
- TRIB 1992
- NAII 1980
- Country
- TRIB Ireland
- NAII United States
- Employees
- TRIB N/A
- NAII N/A
- Industry
- TRIB Biotechnology: In Vitro & In Vivo Diagnostic Substances
- NAII Medicinal Chemicals and Botanical Products
- Sector
- TRIB Health Care
- NAII Health Care
- Exchange
- TRIB Nasdaq
- NAII Nasdaq
- Market Cap
- TRIB 18.3M
- NAII 21.2M
- IPO Year
- TRIB N/A
- NAII 1987
- Fundamental
- Price
- TRIB $0.95
- NAII $3.56
- Analyst Decision
- TRIB
- NAII
- Analyst Count
- TRIB 0
- NAII 0
- Target Price
- TRIB N/A
- NAII N/A
- AVG Volume (30 Days)
- TRIB 67.0K
- NAII 35.8K
- Earning Date
- TRIB 11-14-2025
- NAII 11-12-2025
- Dividend Yield
- TRIB N/A
- NAII N/A
- EPS Growth
- TRIB N/A
- NAII N/A
- EPS
- TRIB N/A
- NAII N/A
- Revenue
- TRIB $61,555,000.00
- NAII $134,440,000.00
- Revenue This Year
- TRIB $13.51
- NAII N/A
- Revenue Next Year
- TRIB $13.14
- NAII N/A
- P/E Ratio
- TRIB N/A
- NAII N/A
- Revenue Growth
- TRIB 8.31
- NAII 19.00
- 52 Week Low
- TRIB $0.48
- NAII $2.57
- 52 Week High
- TRIB $3.44
- NAII $4.70
- Technical
- Relative Strength Index (RSI)
- TRIB 56.27
- NAII 68.63
- Support Level
- TRIB $0.80
- NAII $2.91
- Resistance Level
- TRIB $0.94
- NAII $3.70
- Average True Range (ATR)
- TRIB 0.08
- NAII 0.25
- MACD
- TRIB 0.01
- NAII 0.08
- Stochastic Oscillator
- TRIB 72.73
- NAII 94.68
About TRIB Trinity Biotech plc
Trinity Biotech PLC is in the business of developing, manufacturing, and marketing clinical diagnostic products for clinical laboratory and point-of-care sections of the diagnostic market. Its products are used to detect autoimmune, infectious, sexually transmitted diseases, diabetes, and disorders of the liver and intestine. The company also provides raw materials to the life sciences and research industries globally. It markets products under the brand names Recombigen, Unigold, MarBlot, Mardx, Immublot, and others. Geographically, it has two segments namely the Americas, and the Rest of World - Ireland from which it derives a majority of its revenue from the Americas segment.
About NAII Natural Alternatives International Inc.
Natural Alternatives International Inc is engaged in formulating, manufacturing, and marketing nutritional supplements. It offers vitamins, minerals, herbs, and other supplements, as well as other healthcare products to customers within the United States and internationally. Its business activity is operated through Private-Label Contract Manufacturing and Patent & Trademark Licensing segment. The company derives the majority of revenue from Private-Label Contract Manufacturing which is engaged in providing manufacturing services to companies that market and distribute nutritional supplements and other healthcare products, whereas the Patent and Trademark Licensing segment includes royalty income from its license and supply agreements associated with the sale.